Related Experiment Video
Updated: Aug 29, 2025
10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
6.9K
Stealth nanoparticles in oncology: Facing the PEG dilemma
Sara Zalba1, Timo L M Ten Hagen2, Carmen Burgui3
1Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, University of Navarra; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Summary
Nanoparticles (NPs) enhance drug delivery but face rapid clearance. Polyethylene glycol (PEG)ylation helps, but the "PEG dilemma" poses challenges, necessitating alternative strategies for improved therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Nanoparticles (NPs) offer significant advantages in drug delivery, including improved pharmacokinetics, drug protection, reduced side effects, and controlled release.
- However, NPs are rapidly cleared from systemic circulation by opsonization and the mononuclear phagocyte system (MPS).
Purpose of the Study:
- To review current PEGylation strategies for NPs to overcome rapid clearance.
- To discuss the characteristics of Polyethylene glycol (PEG) and the "PEG dilemma".
- To explore alternative NP surface modification strategies.
Main Methods:
- Literature review of PEGylation strategies for nanoparticles.
- Analysis of Polyethylene glycol (PEG) properties and limitations.
- Examination of alternative camouflage techniques for NPs.
Main Results:
- PEGylation delays NP clearance by forming a hydrophilic layer, but can hinder cellular interactions and cause immune responses (the "PEG dilemma").
- Alternative strategies include cleavable PEG, co-polymerization, and cell membrane-derived camouflage.
Conclusions:
- Addressing the "PEG dilemma" is crucial for effective NP-based therapies.
- Innovative surface modification techniques are essential to enhance NP circulation time and therapeutic efficacy.
